RDHL logo

RedHill Biopharma (RDHL) Selling, General & Administrative Expenses

Annual SGA

$30.98 M
-$33.05 M-51.62%

December 31, 2023

Summary

Performance

1-Year Change

-51.62%

3-Year Change

-58.51%

5-Year Change

+54.94%

15-Year Change

+54.57%

RDHL SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

51.38%
RDHL annual SGA is higher than 51.38% of companies in Healthcare sector

High & Low

All-time High

$87.99 M
RDHL annual SGA is currently -64.80% below its historical high of $87.99 million

3-Year Low

$30.98 M
RDHL annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RDHL previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 8, 2025
RDHL next annual earnings announcement is scheduled for Apr 8, 2025

OtherRDHLexpensesmetrics:

Annual Total Expenses

-$6.10 M
RDHL annual total expenses is -$6.10 million

Annual Operating Expenses

-$9.56 M
RDHL annual total operating expenses is -$9.56 million

Annual Cost Of Goods Sold

$3.46 M
RDHL annual cost of goods sold is $3.46 million

Annual Interest Expense

$367.00 K
RDHL annual interest expense is $367.00 thousand

Quarterly SGA

N/A

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RDHL Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$25.47 M
RDHL quarterly SGA is currently at an all-time high

3-Year Low

$8.06 M
RDHL quarterly SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
RDHL previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
RDHL next earnings announcement is scheduled for Apr 8, 2025

OtherRDHLexpensesmetrics:

Quarterly Total Expenses

-
RDHL quarterly total expenses value is unknown

Quarterly Operating Expenses

-
RDHL quarterly total operating expenses value is unknown

Quarterly Cost Of Goods Sold

-
RDHL quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
RDHL quarterly interest expense value is unknown

TTM SGA

-$410.06 M
+$1.22 B+74.85%

June 1, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-999.66%

3-Year Change

-999.66%

5-Year Change

-999.66%

RDHL TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

65.51%
RDHL TTM SGA is higher than 65.51% of companies in Healthcare sector

High & Low

All-time High

-$15.21 M

3-Year Low

-$1.65 B

Earnings dates

Last Quarterly Earnings Report Date

Jun 1, 2024
RDHL previous earnings announcement was published on Jun 1, 2024

Next Quarterly Earnings Report Date

Apr 8, 2025
RDHL next earnings announcement is scheduled for Apr 8, 2025

OtherRDHLexpensesmetrics:

Annual Total Expenses

-$6.10 M
RDHL annual total expenses is -$6.10 million

Annual Operating Expenses

-$9.56 M
RDHL annual total operating expenses is -$9.56 million

TTM Cost Of Goods Sold

-
RDHL TTM cost of goods sold value is unknown

TTM Interest Expense

-
RDHL TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$30.98 M
RDHL annual SGA is $30.98 million

Annual Operating Expenses

-$9.56 M
RDHL annual total operating expenses is -$9.56 million

Annual Cost Of Goods Sold

$3.46 M
RDHL annual cost of goods sold is $3.46 million

RDHL Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-51.6%--999.7%
3 y3 years-58.5%--999.7%
5 y5 years+54.9%--999.7%

RDHL Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-64.8%at lowat high+75.1%
5 y5-year-64.8%+3.9%at high+75.1%
alltimeall time-64.8%+5879.7%-2596.2%+75.1%

RedHill Biopharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2023
$30.98 M(-51.6%)
-
-
Jun 2023
-
$8.06 M(-26.1%)
$45.58 M(-16.5%)
Mar 2023
-
$10.91 M(-16.2%)
$54.56 M(-14.8%)
Dec 2022
$64.03 M(-27.2%)
$13.02 M(-4.3%)
$64.03 M(-6.6%)
Sep 2022
-
$13.60 M(-20.2%)
$68.58 M(-13.1%)
Jun 2022
-
$17.04 M(-16.4%)
$78.94 M(-9.7%)
Mar 2022
-
$20.38 M(+16.0%)
$87.38 M(-0.7%)
Dec 2021
$87.99 M(+17.9%)
$17.57 M(-26.7%)
$87.99 M(-7.1%)
Sep 2021
-
$23.96 M(-5.9%)
$94.75 M(+3.5%)
Jun 2021
-
$25.47 M(+21.3%)
$91.53 M(+11.5%)
Mar 2021
-
$20.99 M(-13.7%)
$82.06 M(+9.9%)
Dec 2020
$74.66 M(+150.4%)
$24.33 M(+17.3%)
$74.66 M(+23.2%)
Sep 2020
-
$20.74 M(+29.7%)
$60.62 M(+27.1%)
Jun 2020
-
$16.00 M(+17.7%)
$47.70 M(+24.7%)
Mar 2020
-
$13.59 M(+32.1%)
$38.24 M(+28.3%)
Dec 2019
$29.81 M(+49.1%)
$10.29 M(+31.6%)
$29.81 M(+21.4%)
Sep 2019
-
$7.82 M(+19.4%)
$24.56 M(+14.4%)
Jun 2019
-
$6.55 M(+26.8%)
$21.47 M(+7.0%)
Mar 2019
-
$5.16 M(+2.4%)
$20.06 M(+0.3%)
Dec 2018
$19.99 M(-0.2%)
$5.04 M(+6.8%)
$19.99 M(-6.2%)
Sep 2018
-
$4.72 M(-8.1%)
$21.31 M(-7.5%)
Jun 2018
-
$5.14 M(+0.9%)
$23.04 M(-0.8%)
Mar 2018
-
$5.09 M(-19.9%)
$23.21 M(+15.8%)
Dec 2017
$20.04 M
$6.36 M(-1.4%)
$20.04 M(+31.2%)
Sep 2017
-
$6.45 M(+21.3%)
$15.28 M(+49.1%)
DateAnnualQuarterlyTTM
Jun 2017
-
$5.32 M(+176.9%)
$10.25 M(+68.1%)
Mar 2017
-
$1.92 M(+20.3%)
$6.10 M(+12.8%)
Dec 2016
$5.40 M(+30.7%)
$1.60 M(+12.7%)
$5.40 M(-2.1%)
Sep 2016
-
$1.42 M(+21.6%)
$5.52 M(+15.1%)
Jun 2016
-
$1.16 M(-5.1%)
$4.80 M(+8.2%)
Mar 2016
-
$1.23 M(-28.4%)
$4.43 M(+7.3%)
Dec 2015
$4.13 M(+3.1%)
$1.71 M(+147.7%)
$4.13 M(+17.1%)
Sep 2015
-
$692.00 K(-13.6%)
$3.53 M(-5.9%)
Jun 2015
-
$801.00 K(-13.6%)
$3.75 M(-4.1%)
Mar 2015
-
$927.00 K(-16.6%)
$3.91 M(-2.5%)
Dec 2014
$4.01 M(+49.4%)
$1.11 M(+21.8%)
$4.01 M(+5.1%)
Sep 2014
-
$912.00 K(-5.1%)
$3.82 M(+10.6%)
Jun 2014
-
$961.00 K(-6.4%)
$3.45 M(+13.6%)
Mar 2014
-
$1.03 M(+12.1%)
$3.04 M(+13.1%)
Dec 2013
$2.68 M(+3.2%)
$916.00 K(+68.1%)
$2.68 M(+1.7%)
Sep 2013
-
$545.00 K(-0.5%)
$2.64 M(-0.2%)
Jun 2013
-
$548.00 K(-18.8%)
$2.64 M(-1.1%)
Mar 2013
-
$675.00 K(-22.5%)
$2.67 M(+2.5%)
Dec 2012
$2.60 M(+4.8%)
$871.00 K(+58.4%)
$2.61 M(+11.3%)
Sep 2012
-
$550.00 K(-4.8%)
$2.34 M(-5.5%)
Jun 2012
-
$578.00 K(-5.1%)
$2.48 M(+30.4%)
Mar 2012
-
$609.00 K(+0.3%)
$1.90 M(+47.1%)
Dec 2011
$2.48 M(+379.2%)
$607.00 K(-11.6%)
$1.29 M(+88.4%)
Sep 2011
-
$687.00 K
$687.00 K
Dec 2010
$518.00 K
-
-

FAQ

  • What is RedHill Biopharma annual SGA?
  • What is the all time high annual SGA for RedHill Biopharma?
  • What is RedHill Biopharma annual SGA year-on-year change?
  • What is the all time high quarterly SGA for RedHill Biopharma?
  • What is RedHill Biopharma TTM SGA?
  • What is the all time high TTM SGA for RedHill Biopharma?
  • What is RedHill Biopharma TTM SGA year-on-year change?

What is RedHill Biopharma annual SGA?

The current annual SGA of RDHL is $30.98 M

What is the all time high annual SGA for RedHill Biopharma?

RedHill Biopharma all-time high annual SGA is $87.99 M

What is RedHill Biopharma annual SGA year-on-year change?

Over the past year, RDHL annual SGA has changed by -$33.05 M (-51.62%)

What is the all time high quarterly SGA for RedHill Biopharma?

RedHill Biopharma all-time high quarterly SGA is $25.47 M

What is RedHill Biopharma TTM SGA?

The current TTM SGA of RDHL is -$410.06 M

What is the all time high TTM SGA for RedHill Biopharma?

RedHill Biopharma all-time high TTM SGA is -$15.21 M

What is RedHill Biopharma TTM SGA year-on-year change?

Over the past year, RDHL TTM SGA has changed by -$455.64 M (-999.66%)